| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glucans | 23 | 2025 | 63 | 2.970 |
Why?
|
| beta-Glucans | 19 | 2021 | 47 | 2.600 |
Why?
|
| Saccharomyces cerevisiae | 17 | 2023 | 530 | 1.940 |
Why?
|
| Terpenes | 3 | 2023 | 25 | 1.720 |
Why?
|
| Vaccines | 6 | 2023 | 97 | 1.520 |
Why?
|
| Anthelmintics | 7 | 2024 | 42 | 1.450 |
Why?
|
| Fungal Vaccines | 10 | 2020 | 44 | 1.340 |
Why?
|
| Nematoda | 5 | 2024 | 34 | 1.290 |
Why?
|
| Adjuvants, Immunologic | 10 | 2021 | 228 | 1.220 |
Why?
|
| Oils, Volatile | 1 | 2023 | 21 | 0.830 |
Why?
|
| Humic Substances | 2 | 2021 | 4 | 0.820 |
Why?
|
| Aflatoxin B1 | 2 | 2021 | 6 | 0.820 |
Why?
|
| Disinfectants | 1 | 2022 | 20 | 0.800 |
Why?
|
| Nanoparticles | 6 | 2021 | 498 | 0.790 |
Why?
|
| Antigens, Fungal | 7 | 2022 | 54 | 0.790 |
Why?
|
| Cryptococcosis | 5 | 2022 | 71 | 0.780 |
Why?
|
| Nematode Infections | 2 | 2024 | 11 | 0.770 |
Why?
|
| Cryptococcus neoformans | 5 | 2022 | 141 | 0.740 |
Why?
|
| Cell Wall | 5 | 2021 | 113 | 0.730 |
Why?
|
| Coccidioides | 5 | 2020 | 10 | 0.710 |
Why?
|
| Coccidioidomycosis | 5 | 2020 | 11 | 0.710 |
Why?
|
| Animals | 53 | 2025 | 19641 | 0.690 |
Why?
|
| Mice | 35 | 2025 | 10272 | 0.580 |
Why?
|
| Tularemia | 3 | 2024 | 17 | 0.550 |
Why?
|
| Francisella tularensis | 3 | 2024 | 23 | 0.550 |
Why?
|
| Vaccination | 8 | 2019 | 338 | 0.550 |
Why?
|
| Hemolysin Proteins | 3 | 2024 | 45 | 0.540 |
Why?
|
| Endotoxins | 3 | 2024 | 79 | 0.530 |
Why?
|
| Bacterial Vaccines | 3 | 2024 | 90 | 0.520 |
Why?
|
| Drug Delivery Systems | 6 | 2025 | 309 | 0.500 |
Why?
|
| Antigens | 4 | 2023 | 146 | 0.490 |
Why?
|
| Bacterial Proteins | 5 | 2024 | 749 | 0.430 |
Why?
|
| Ovalbumin | 6 | 2017 | 114 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 21 | 2025 | 3192 | 0.410 |
Why?
|
| Bacillus thuringiensis | 3 | 2024 | 20 | 0.410 |
Why?
|
| Lectins, C-Type | 4 | 2020 | 82 | 0.410 |
Why?
|
| Vaccines, Subunit | 5 | 2024 | 40 | 0.390 |
Why?
|
| Macrophages | 9 | 2025 | 1004 | 0.380 |
Why?
|
| Fungi | 3 | 2020 | 50 | 0.380 |
Why?
|
| Chitin | 5 | 2019 | 39 | 0.350 |
Why?
|
| Ascomycota | 2 | 2015 | 11 | 0.340 |
Why?
|
| Hookworm Infections | 2 | 2021 | 10 | 0.340 |
Why?
|
| Ancylostomatoidea | 2 | 2020 | 12 | 0.330 |
Why?
|
| Gene Transfer Techniques | 2 | 2011 | 304 | 0.330 |
Why?
|
| Huntingtin Protein | 3 | 2020 | 138 | 0.330 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 2067 | 0.320 |
Why?
|
| Th17 Cells | 5 | 2021 | 54 | 0.310 |
Why?
|
| Dendritic Cells | 5 | 2015 | 508 | 0.290 |
Why?
|
| Cryptococcus gattii | 2 | 2017 | 12 | 0.270 |
Why?
|
| Rats, Inbred F344 | 2 | 2024 | 52 | 0.270 |
Why?
|
| DNA | 2 | 2008 | 792 | 0.260 |
Why?
|
| Ancylostoma | 3 | 2020 | 24 | 0.250 |
Why?
|
| Peyer's Patches | 2 | 2015 | 35 | 0.240 |
Why?
|
| Lipids | 2 | 2025 | 306 | 0.240 |
Why?
|
| Recombinant Proteins | 7 | 2021 | 692 | 0.230 |
Why?
|
| Antitubercular Agents | 1 | 2025 | 77 | 0.230 |
Why?
|
| Huntington Disease | 2 | 2017 | 146 | 0.220 |
Why?
|
| Albendazole | 2 | 2020 | 9 | 0.220 |
Why?
|
| Drug Carriers | 2 | 2017 | 171 | 0.220 |
Why?
|
| Yeasts | 2 | 2018 | 51 | 0.220 |
Why?
|
| Lung | 8 | 2025 | 833 | 0.220 |
Why?
|
| Anthrax | 1 | 2003 | 13 | 0.210 |
Why?
|
| Mice, Inbred BALB C | 7 | 2019 | 879 | 0.210 |
Why?
|
| Proteoglycans | 2 | 2021 | 33 | 0.210 |
Why?
|
| Cytokines | 7 | 2020 | 905 | 0.210 |
Why?
|
| Fungal Proteins | 3 | 2019 | 142 | 0.210 |
Why?
|
| Silicon Dioxide | 1 | 2023 | 59 | 0.210 |
Why?
|
| CD4-Positive T-Lymphocytes | 6 | 2018 | 608 | 0.200 |
Why?
|
| Escherichia coli | 6 | 2019 | 685 | 0.200 |
Why?
|
| Ancylostomiasis | 2 | 2019 | 11 | 0.200 |
Why?
|
| Fungal Polysaccharides | 1 | 2021 | 4 | 0.200 |
Why?
|
| Mycoses | 2 | 2020 | 41 | 0.190 |
Why?
|
| Cloning, Molecular | 4 | 2017 | 385 | 0.190 |
Why?
|
| Drug Compounding | 1 | 2022 | 74 | 0.190 |
Why?
|
| Capsules | 1 | 2021 | 31 | 0.190 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 139 | 0.190 |
Why?
|
| Mannans | 2 | 2018 | 19 | 0.180 |
Why?
|
| Parasites | 1 | 2021 | 10 | 0.180 |
Why?
|
| Sheep Diseases | 1 | 2020 | 4 | 0.180 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 58 | 0.180 |
Why?
|
| Pharmaceutical Preparations | 1 | 2022 | 122 | 0.180 |
Why?
|
| Haemonchiasis | 1 | 2020 | 4 | 0.180 |
Why?
|
| Haemonchus | 1 | 2020 | 5 | 0.180 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2025 | 383 | 0.180 |
Why?
|
| Vaccines, Combined | 1 | 2020 | 7 | 0.180 |
Why?
|
| Probiotics | 1 | 2020 | 41 | 0.170 |
Why?
|
| Host-Pathogen Interactions | 2 | 2020 | 238 | 0.170 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2020 | 63 | 0.170 |
Why?
|
| Disease Resistance | 1 | 2020 | 19 | 0.170 |
Why?
|
| Benzimidazoles | 1 | 2020 | 59 | 0.170 |
Why?
|
| Strongyloides stercoralis | 1 | 2019 | 12 | 0.170 |
Why?
|
| Bacillus subtilis | 3 | 1984 | 33 | 0.170 |
Why?
|
| Cysteine Proteases | 1 | 2019 | 3 | 0.160 |
Why?
|
| Zea mays | 1 | 2019 | 23 | 0.160 |
Why?
|
| Antibodies, Helminth | 1 | 2019 | 10 | 0.160 |
Why?
|
| Antigens, Helminth | 1 | 2019 | 8 | 0.160 |
Why?
|
| Cell Movement | 2 | 2020 | 422 | 0.160 |
Why?
|
| Plasmids | 3 | 1984 | 282 | 0.160 |
Why?
|
| Protozoan Vaccines | 1 | 2018 | 13 | 0.160 |
Why?
|
| Antigens, Surface | 2 | 2019 | 191 | 0.160 |
Why?
|
| Receptors, CCR2 | 1 | 2018 | 14 | 0.150 |
Why?
|
| Ferric Compounds | 1 | 2018 | 38 | 0.150 |
Why?
|
| Immunity, Cellular | 3 | 2018 | 176 | 0.150 |
Why?
|
| Chlorides | 1 | 2018 | 31 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 31 | 0.150 |
Why?
|
| Multiple Sclerosis | 1 | 2021 | 208 | 0.150 |
Why?
|
| Adsorption | 1 | 2018 | 85 | 0.150 |
Why?
|
| Histoplasma | 1 | 2018 | 15 | 0.150 |
Why?
|
| Melanoma, Experimental | 1 | 2018 | 42 | 0.150 |
Why?
|
| Histoplasmosis | 1 | 2018 | 23 | 0.150 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2018 | 26 | 0.150 |
Why?
|
| alpha-Synuclein | 1 | 2017 | 20 | 0.150 |
Why?
|
| Immunologic Memory | 1 | 2020 | 276 | 0.140 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 169 | 0.140 |
Why?
|
| Myeloid Cells | 2 | 2017 | 92 | 0.140 |
Why?
|
| Vaccines, Synthetic | 4 | 2019 | 68 | 0.140 |
Why?
|
| Intestines | 1 | 2018 | 156 | 0.140 |
Why?
|
| Lung Diseases, Fungal | 2 | 2017 | 31 | 0.140 |
Why?
|
| Hydrodynamics | 1 | 2017 | 33 | 0.140 |
Why?
|
| Humans | 26 | 2025 | 59422 | 0.140 |
Why?
|
| Mutant Proteins | 1 | 2017 | 105 | 0.140 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2020 | 177 | 0.140 |
Why?
|
| Rats | 5 | 2024 | 1913 | 0.130 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 851 | 0.130 |
Why?
|
| Monocytes | 1 | 2018 | 345 | 0.130 |
Why?
|
| Trans-Activators | 1 | 2018 | 295 | 0.130 |
Why?
|
| Staining and Labeling | 1 | 2017 | 124 | 0.130 |
Why?
|
| Candida tropicalis | 1 | 2015 | 2 | 0.130 |
Why?
|
| Female | 14 | 2025 | 30883 | 0.130 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2017 | 196 | 0.130 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 127 | 0.130 |
Why?
|
| Carbohydrates | 2 | 2014 | 42 | 0.130 |
Why?
|
| Cells, Cultured | 6 | 2020 | 2099 | 0.130 |
Why?
|
| Mannose-Binding Lectins | 1 | 2015 | 21 | 0.130 |
Why?
|
| Complement C3 | 3 | 2012 | 61 | 0.130 |
Why?
|
| Cell Membrane | 1 | 2018 | 490 | 0.130 |
Why?
|
| Immunity, Humoral | 2 | 2017 | 41 | 0.120 |
Why?
|
| Calnexin | 1 | 2015 | 5 | 0.120 |
Why?
|
| Candida albicans | 1 | 2015 | 54 | 0.120 |
Why?
|
| Water | 1 | 2017 | 295 | 0.120 |
Why?
|
| Chitosan | 2 | 2014 | 82 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 453 | 0.120 |
Why?
|
| NF-kappa B | 2 | 2014 | 461 | 0.110 |
Why?
|
| Immunity, Active | 1 | 2013 | 10 | 0.110 |
Why?
|
| Interferon-gamma | 3 | 2022 | 541 | 0.110 |
Why?
|
| Hemostatics | 1 | 2014 | 26 | 0.110 |
Why?
|
| Drosophila melanogaster | 1 | 2018 | 480 | 0.110 |
Why?
|
| Cell Line | 1 | 2018 | 2012 | 0.110 |
Why?
|
| Immunization | 3 | 2020 | 127 | 0.110 |
Why?
|
| Epitopes | 1 | 2015 | 295 | 0.110 |
Why?
|
| Genetic Vectors | 3 | 1984 | 813 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 2 | 2014 | 420 | 0.110 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 231 | 0.110 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 758 | 0.110 |
Why?
|
| Drosophila Proteins | 1 | 2018 | 682 | 0.100 |
Why?
|
| Male | 15 | 2021 | 27545 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 555 | 0.100 |
Why?
|
| Th1 Cells | 3 | 2018 | 172 | 0.100 |
Why?
|
| T-Lymphocytes | 3 | 2024 | 964 | 0.100 |
Why?
|
| Peritonitis | 1 | 1992 | 33 | 0.100 |
Why?
|
| Properdin | 1 | 2011 | 14 | 0.100 |
Why?
|
| Inflammation | 2 | 2009 | 1097 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2020 | 2886 | 0.100 |
Why?
|
| Complement Pathway, Alternative | 1 | 2011 | 27 | 0.090 |
Why?
|
| Phagocytes | 1 | 2011 | 49 | 0.090 |
Why?
|
| Complement Activation | 1 | 2011 | 53 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2015 | 942 | 0.090 |
Why?
|
| Polysaccharides | 1 | 2011 | 145 | 0.090 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 1223 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 2 | 2004 | 856 | 0.080 |
Why?
|
| Granulocytes | 2 | 2003 | 66 | 0.080 |
Why?
|
| Cricetinae | 2 | 2021 | 376 | 0.080 |
Why?
|
| Intestinal Diseases, Parasitic | 2 | 2019 | 14 | 0.080 |
Why?
|
| Mice, Knockout | 4 | 2018 | 1988 | 0.080 |
Why?
|
| Porosity | 1 | 2008 | 38 | 0.080 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 96 | 0.070 |
Why?
|
| Fluorescence | 1 | 2008 | 84 | 0.070 |
Why?
|
| RNA, Transfer | 1 | 2008 | 77 | 0.070 |
Why?
|
| Phagocytosis | 3 | 2020 | 252 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2019 | 796 | 0.070 |
Why?
|
| Toll-Like Receptors | 1 | 2009 | 434 | 0.070 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 162 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2018 | 553 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2009 | 376 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 354 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 396 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2008 | 638 | 0.070 |
Why?
|
| Transfection | 1 | 2008 | 674 | 0.070 |
Why?
|
| Clofazimine | 1 | 2025 | 5 | 0.060 |
Why?
|
| Linezolid | 1 | 2025 | 10 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2025 | 27 | 0.060 |
Why?
|
| Isoniazid | 1 | 2025 | 14 | 0.060 |
Why?
|
| HT29 Cells | 2 | 2015 | 27 | 0.060 |
Why?
|
| Caco-2 Cells | 2 | 2015 | 65 | 0.060 |
Why?
|
| Immunoglobulin G | 2 | 2019 | 452 | 0.060 |
Why?
|
| Transformation, Bacterial | 1 | 1983 | 12 | 0.060 |
Why?
|
| Trichoderma | 1 | 2003 | 2 | 0.060 |
Why?
|
| Hymecromone | 1 | 2003 | 2 | 0.060 |
Why?
|
| Serratia marcescens | 1 | 2003 | 6 | 0.060 |
Why?
|
| Chitinases | 1 | 2003 | 10 | 0.060 |
Why?
|
| Acetylglucosamine | 1 | 2003 | 11 | 0.060 |
Why?
|
| Streptomyces | 1 | 2003 | 19 | 0.060 |
Why?
|
| Genotype | 3 | 2017 | 636 | 0.050 |
Why?
|
| Gene Expression | 2 | 2017 | 807 | 0.050 |
Why?
|
| Biological Warfare | 1 | 2003 | 3 | 0.050 |
Why?
|
| Bacillus anthracis | 1 | 2003 | 12 | 0.050 |
Why?
|
| Bioterrorism | 1 | 2003 | 11 | 0.050 |
Why?
|
| Species Specificity | 2 | 2019 | 335 | 0.050 |
Why?
|
| Antigens, Bacterial | 1 | 2024 | 214 | 0.050 |
Why?
|
| Gingivitis | 1 | 2002 | 6 | 0.050 |
Why?
|
| Porphyromonas gingivalis | 1 | 2002 | 16 | 0.050 |
Why?
|
| Amidohydrolases | 1 | 2022 | 35 | 0.050 |
Why?
|
| Horses | 1 | 2022 | 49 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2021 | 569 | 0.050 |
Why?
|
| Mice, Inbred Strains | 2 | 2012 | 182 | 0.050 |
Why?
|
| Neutrophil Infiltration | 1 | 2002 | 61 | 0.050 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2021 | 7 | 0.050 |
Why?
|
| Tuberculosis | 1 | 2025 | 262 | 0.050 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2021 | 10 | 0.050 |
Why?
|
| Freund's Adjuvant | 1 | 2021 | 13 | 0.050 |
Why?
|
| Cytosol | 1 | 2022 | 169 | 0.050 |
Why?
|
| Immunotherapy | 1 | 2003 | 231 | 0.050 |
Why?
|
| Lymphoid Tissue | 2 | 2015 | 55 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2017 | 5170 | 0.050 |
Why?
|
| Goats | 1 | 2020 | 9 | 0.050 |
Why?
|
| Parasite Egg Count | 1 | 2020 | 6 | 0.050 |
Why?
|
| Bacterial Infections | 1 | 2002 | 138 | 0.050 |
Why?
|
| Survival Rate | 1 | 2003 | 790 | 0.040 |
Why?
|
| Sheep | 1 | 2020 | 166 | 0.040 |
Why?
|
| Administration, Oral | 2 | 2013 | 344 | 0.040 |
Why?
|
| Interleukin-1beta | 2 | 2014 | 264 | 0.040 |
Why?
|
| Feces | 1 | 2020 | 97 | 0.040 |
Why?
|
| Peptides | 2 | 2021 | 545 | 0.040 |
Why?
|
| Cattle | 1 | 2020 | 304 | 0.040 |
Why?
|
| Ivermectin | 1 | 2019 | 10 | 0.040 |
Why?
|
| Receptors, CXCR3 | 1 | 2020 | 34 | 0.040 |
Why?
|
| Zymosan | 2 | 2011 | 23 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 52 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2020 | 185 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2021 | 349 | 0.040 |
Why?
|
| Larva | 1 | 2019 | 128 | 0.040 |
Why?
|
| Avena | 1 | 1999 | 7 | 0.040 |
Why?
|
| Mesocricetus | 1 | 2019 | 93 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2022 | 922 | 0.040 |
Why?
|
| HLA-DR4 Antigen | 1 | 2018 | 9 | 0.040 |
Why?
|
| Vaccines, Attenuated | 1 | 2018 | 35 | 0.040 |
Why?
|
| Antigens, Protozoan | 1 | 2018 | 37 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2018 | 93 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 739 | 0.040 |
Why?
|
| Necatoriasis | 1 | 2018 | 2 | 0.040 |
Why?
|
| Necator americanus | 1 | 2018 | 2 | 0.040 |
Why?
|
| Intestinal Absorption | 1 | 2018 | 28 | 0.040 |
Why?
|
| Dietary Fiber | 1 | 1999 | 86 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 620 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 454 | 0.040 |
Why?
|
| Interleukin-17 | 1 | 2018 | 82 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 87 | 0.040 |
Why?
|
| Sirolimus | 1 | 2017 | 76 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2018 | 243 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 117 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 724 | 0.030 |
Why?
|
| Digestion | 1 | 2018 | 132 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 501 | 0.030 |
Why?
|
| Dogs | 1 | 2018 | 310 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 220 | 0.030 |
Why?
|
| Oligosaccharides | 2 | 2003 | 62 | 0.030 |
Why?
|
| Psoriasis | 2 | 1973 | 51 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2017 | 303 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 2015 | 65 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2015 | 70 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 858 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 1576 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 422 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2009 | 321 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 119 | 0.030 |
Why?
|
| Mutation | 1 | 1983 | 2443 | 0.030 |
Why?
|
| Alveolar Bone Loss | 1 | 1995 | 4 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 135 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2015 | 253 | 0.030 |
Why?
|
| Neutrophil Activation | 1 | 1995 | 24 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 219 | 0.030 |
Why?
|
| Biomarkers | 1 | 2020 | 1199 | 0.030 |
Why?
|
| Immunoconjugates | 1 | 2014 | 84 | 0.030 |
Why?
|
| U937 Cells | 1 | 2014 | 8 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 525 | 0.030 |
Why?
|
| Neoplasms | 1 | 2004 | 1244 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 2 | 2004 | 30 | 0.030 |
Why?
|
| Polyglycolic Acid | 1 | 2014 | 16 | 0.030 |
Why?
|
| Vaccines, Live, Unattenuated | 1 | 2013 | 2 | 0.030 |
Why?
|
| Protein Binding | 1 | 2018 | 1548 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2014 | 70 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 590 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 557 | 0.030 |
Why?
|
| Genes, Bacterial | 2 | 1984 | 117 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 202 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 2013 | 93 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2018 | 1293 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 1992 | 24 | 0.030 |
Why?
|
| Antibodies, Blocking | 1 | 2012 | 40 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2012 | 190 | 0.030 |
Why?
|
| Rats, Inbred Strains | 1 | 1992 | 151 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1992 | 94 | 0.020 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2014 | 256 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 1992 | 69 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1992 | 148 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 448 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2011 | 83 | 0.020 |
Why?
|
| Child | 1 | 2021 | 4306 | 0.020 |
Why?
|
| Base Sequence | 2 | 1984 | 1311 | 0.020 |
Why?
|
| COS Cells | 1 | 2011 | 174 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2443 | 0.020 |
Why?
|
| Ligands | 1 | 2012 | 420 | 0.020 |
Why?
|
| Bacteria | 1 | 1973 | 275 | 0.020 |
Why?
|
| Inflammasomes | 1 | 2014 | 331 | 0.020 |
Why?
|
| Phenotype | 2 | 1984 | 1150 | 0.020 |
Why?
|
| Particle Size | 1 | 2011 | 399 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2014 | 709 | 0.020 |
Why?
|
| Uridine Diphosphate Sugars | 1 | 1989 | 2 | 0.020 |
Why?
|
| Cytidine Monophosphate N-Acetylneuraminic Acid | 1 | 1989 | 12 | 0.020 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 1989 | 9 | 0.020 |
Why?
|
| Lactose | 1 | 1989 | 13 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 179 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 125 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 123 | 0.020 |
Why?
|
| Sialic Acids | 1 | 1989 | 46 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2009 | 353 | 0.020 |
Why?
|
| Hyaluronic Acid | 1 | 1989 | 63 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2014 | 762 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2009 | 305 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2009 | 363 | 0.020 |
Why?
|
| Adult | 2 | 2017 | 15762 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 201 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 1537 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 582 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 645 | 0.020 |
Why?
|
| Fusaric Acid | 1 | 1984 | 1 | 0.010 |
Why?
|
| Chimera | 1 | 1984 | 42 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1984 | 60 | 0.010 |
Why?
|
| Complement C3b | 1 | 2003 | 20 | 0.010 |
Why?
|
| DNA Restriction Enzymes | 1 | 1984 | 35 | 0.010 |
Why?
|
| Brachyura | 1 | 2003 | 1 | 0.010 |
Why?
|
| Complex Mixtures | 1 | 2003 | 5 | 0.010 |
Why?
|
| Disaccharides | 1 | 2003 | 10 | 0.010 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2003 | 13 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 2003 | 18 | 0.010 |
Why?
|
| Trisaccharides | 1 | 2003 | 9 | 0.010 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2003 | 22 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1983 | 104 | 0.010 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2003 | 62 | 0.010 |
Why?
|
| Glucosamine | 1 | 2003 | 31 | 0.010 |
Why?
|
| Colloids | 1 | 2003 | 50 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2009 | 841 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2003 | 137 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2003 | 197 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2002 | 43 | 0.010 |
Why?
|
| Models, Animal | 1 | 2002 | 221 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 729 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 13334 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2002 | 576 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2003 | 323 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 16248 | 0.010 |
Why?
|
| Neutrophils | 1 | 2002 | 352 | 0.010 |
Why?
|
| Carbohydrate Conformation | 1 | 1999 | 15 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 1999 | 68 | 0.010 |
Why?
|
| History, 20th Century | 1 | 1999 | 226 | 0.010 |
Why?
|
| Cholesterol | 1 | 1999 | 255 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1999 | 442 | 0.010 |
Why?
|
| Polymers | 1 | 1958 | 316 | 0.010 |
Why?
|
| Dental Pulp Necrosis | 1 | 1995 | 2 | 0.010 |
Why?
|
| Bacteria, Anaerobic | 1 | 1995 | 5 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 3577 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1995 | 96 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1995 | 401 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1995 | 483 | 0.010 |
Why?
|
| Sterilization | 1 | 1972 | 16 | 0.010 |
Why?
|
| Wound Healing | 1 | 1972 | 176 | 0.010 |
Why?
|
| Skin | 1 | 1972 | 356 | 0.010 |
Why?
|
| Cytidine Triphosphate | 1 | 1989 | 1 | 0.010 |
Why?
|
| Clostridium perfringens | 1 | 1989 | 3 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1989 | 43 | 0.000 |
Why?
|
| Neuraminidase | 1 | 1989 | 49 | 0.000 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 1989 | 49 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1989 | 293 | 0.000 |
Why?
|
| Cytochrome Reductases | 1 | 1960 | 3 | 0.000 |
Why?
|
| Oxidoreductases | 1 | 1960 | 65 | 0.000 |
Why?
|
| Oxidation-Reduction | 1 | 1960 | 305 | 0.000 |
Why?
|
| Viruses | 1 | 1960 | 79 | 0.000 |
Why?
|
| Fatty Acids | 1 | 1960 | 193 | 0.000 |
Why?
|
| Colitis | 1 | 1960 | 76 | 0.000 |
Why?
|
| Colitis, Ulcerative | 1 | 1960 | 84 | 0.000 |
Why?
|
| Hodgkin Disease | 1 | 1956 | 56 | 0.000 |
Why?
|
| Immunity | 1 | 1956 | 96 | 0.000 |
Why?
|
| Surgical Wound Infection | 1 | 1972 | 108 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1972 | 114 | 0.000 |
Why?
|